Recently, there has seen reports about a uncommon condition that involves blood clots and abnormal bleeding following vaccination. The issue is being studied but the risks associated with this particular condition aren't yet evident.
This condition may also happen in the natural course, and clotting issues are a typical consequence of COVID-19 infection. A higher risk of developing the condition has not yet been identified following other COVID-19 vaccines, however it is being closely monitored.
Blood clots are formed when blood is coagulated inside blood vessels is a significant cause of cardiovascular diseases. Serratiopeptidase can be described as a serine protease is a substrate-specific enzyme with fibrinolytic capacity . Serratiopeptidase is demonstrated to have the capability of blood clot lysis and can remove the blockages and cysts in the arterial system .
Serrapeptase could be helpful in treating atherosclerosis. This is which is a condition in which plaque build-ups within your blood vessels.
It's believed that it acts by dissolving damaged or dead tissues and fibrin, the tough protein that forms by blood clots.
This can allow serrapeptase dissolve plaques in your arteries and remove blood clots which could cause strokes as well as heart attack.
But, a lot of information regarding its capacity to break blood clots more based on personal experiences than factual information.
Thus, further research is needed to establish the role serrapeptase is playing in removing blood clots.